Clinical Trials › NCT06133049
Active, Not Recruiting
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Sponsored by Bristol-Myers Squibb
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 2961
Target enrollment
1
U.S. states
Mar 2021
Start date
Aug 2031
Expected completion
Interventions / Treatments
OzanimodSelect DMTs other than ozanimodNo DMTs
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Minnesota1 site
Eden Prairie
MS centers in Minnesota
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Minnesota centersCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
